His book, “American Ramble,” lyrically recounted a 330-mile trek from Washington, D.C., to New York City while he was in ...
By way of two resoundingly consistent votes, members of an FDA advisory committee agreed that PD-1 inhibitors do not have a favorable risk/benefit profile for gastroesophageal cancers with low PD-L1 ...
Gastroenterologists warned that chronic heartburn could raise the risk of esophageal and throat cancers, which are on the ...
New data show Talvey’s potential in multiple myeloma drug combinations. Elsewhere, AbbVie got more positive Parkinson’s drug ...
Over 54 pages, the report paints a picture of a VA Western New York Healthcare System where local system administrators ...
Another explanation for the gas effect? The high-fiber content of prebiotic sodas. Research suggests that a high intake of ...
I heard everything he said, but I can’t remember anything he said. I remember that he cried, but also that he laughed. He wore his emotions like a second skin, and despite his difficult life his def ...
The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.
The General Assembly will not hold a special meeting to override Gov. John Carney's veto of House Bill 140, the end-of-life ...
Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer ...
A recent report by the American Association for Cancer Research suggests adding cancer-specific warning labels to alcoholic ...
The hormone decreases a type of white blood cell that helps keep tumors in check; restricting the hormone could be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback